Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney Perry

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Crohn'S & Colitis 360|July 25, 2024
Applying Machine Learning Models Derived From Administrative Claims Data to Predict Medication Nonadherence in Patients Self-Administering Biologic Medications for Inflammatory Bowel DiseaseChristian Rhudy, Courtney Perry, Michael Wesley, et al.
International Journal of Medical Informatics|August 17, 2025
Machine learning approaches to predicting medication nonadherence: a scoping reviewChristian Rhudy, Jacob Johnson, Courtney Perry, et al.
Archives of Physical Medicine and Rehabilitation|October 6, 2025
Fear-Avoidant Adults Have Worse Clinical Outcomes and Recovery Time After ConcussionAlicia M Trbovich, Aaron J Zynda, Anne Mucha, et al.
Scientific Reports|November 20, 2020
Hepatocyte nuclear factor 1 alpha influences pancreatic cancer growth and metastasisRamadevi Subramani, Joshua Medel, Kristina Flores, et al.
Neuropsychology|August 25, 2025
Comparison of multidomain assessment outcomes between older and middle-aged adults following concussionNathan R Ramirez, Aaron J Zynda, Courtney Perry, et al.
Crohn'S & Colitis 360|January 27, 2025
Dual Biologic Therapy Induces Remission in Refractory Crohn's Disease With Vedolizumab and UstekinumabSyed Adeel Hassan, Courtney Perry, Patrick Carey, et al.
Digestive Diseases and Sciences|July 26, 2020
Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative ColitisCourtney Perry, Kyle Fischer, Ahmed Elmoursi, et al.
Antioxidants (Basel, Switzerland)|October 28, 2023
Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and MetastasisTugba Mehmetoglu-Gurbuz, Rajkumar Lakshmanaswamy, Karla Perez, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 28, 2025
Role of anxiety in exercise intolerance and autonomic nervous system dysfunction post-concussionAaron J Zynda, Alicia M Trbovich, Faith Kehinde, et al.
Therapeutic Advances in Gastroenterology|November 2, 2020
Ustekinumab dose escalation improves clinical responses in refractory Crohn's diseaseSyedreza A Haider, Abhijeet Yadav, Courtney Perry, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Crohn'S & Colitis 360|July 25, 2024
Applying Machine Learning Models Derived From Administrative Claims Data to Predict Medication Nonadherence in Patients Self-Administering Biologic Medications for Inflammatory Bowel DiseaseChristian Rhudy, Courtney Perry, Michael Wesley, et al.
International Journal of Medical Informatics|August 17, 2025
Machine learning approaches to predicting medication nonadherence: a scoping reviewChristian Rhudy, Jacob Johnson, Courtney Perry, et al.
Archives of Physical Medicine and Rehabilitation|October 6, 2025
Fear-Avoidant Adults Have Worse Clinical Outcomes and Recovery Time After ConcussionAlicia M Trbovich, Aaron J Zynda, Anne Mucha, et al.
Scientific Reports|November 20, 2020
Hepatocyte nuclear factor 1 alpha influences pancreatic cancer growth and metastasisRamadevi Subramani, Joshua Medel, Kristina Flores, et al.
Neuropsychology|August 25, 2025
Comparison of multidomain assessment outcomes between older and middle-aged adults following concussionNathan R Ramirez, Aaron J Zynda, Courtney Perry, et al.
Crohn'S & Colitis 360|January 27, 2025
Dual Biologic Therapy Induces Remission in Refractory Crohn's Disease With Vedolizumab and UstekinumabSyed Adeel Hassan, Courtney Perry, Patrick Carey, et al.
Digestive Diseases and Sciences|July 26, 2020
Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative ColitisCourtney Perry, Kyle Fischer, Ahmed Elmoursi, et al.
Antioxidants (Basel, Switzerland)|October 28, 2023
Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and MetastasisTugba Mehmetoglu-Gurbuz, Rajkumar Lakshmanaswamy, Karla Perez, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 28, 2025
Role of anxiety in exercise intolerance and autonomic nervous system dysfunction post-concussionAaron J Zynda, Alicia M Trbovich, Faith Kehinde, et al.
Therapeutic Advances in Gastroenterology|November 2, 2020
Ustekinumab dose escalation improves clinical responses in refractory Crohn's diseaseSyedreza A Haider, Abhijeet Yadav, Courtney Perry, et al.
Pageof 3